Decreased proliferative capability of CD4+ cells of elderly people is associated with faster loss of activation-related antigens and accumulation of regulatory T cells

Experimental Gerontology

Volumn 39, Issue 4, 2004, Pages 587-595

  Bryl, Ewa ^a   Witkowski, Jacek M ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Aging; Apoptosis; Cell cycle; Human; Regulatory T cell

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD28 ANTIGEN; CD4 ANTIGEN; CD69 ANTIGEN; CYCLINE; INTERLEUKIN 2 RECEPTOR;

ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; CELL DIVISION; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; LYMPHOCYTE DIFFERENTIATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; STAINING; SUPPRESSOR CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; AGING; ANTIGENS, CD; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL AGING; CELL DIVISION; CELLS, CULTURED; HUMANS; LYMPHOCYTE ACTIVATION; MIDDLE AGED; PROLIFERATING CELL NUCLEAR ANTIGEN; T-LYMPHOCYTE SUBSETS;

EID: 1642421839     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2003.10.029     Document Type: Conference Paper

References (36)

1. Boucher N., Dufeu-Duchesne T., Vicaut E., Farge D., Effros R.B., Schachter F. CD28 expression in T cell aging and human longevity. Exp. Gerontol. 33:1998;267-282.
2. Bryl E., Gazda M., Foerster J., Witkowski J.M. Age-related increase of frequency of a new, phenotypically distinct subpopulation of human peripheral blood T cells expressing lowered levels of CD4. Blood. 98:2001;1100-1107.
3. Cossarizza A., Ortolani C., Monti D., Franceschi C. Cytometric analysis of immunosenescence. Cytometry. 27:1997;297-313.
4. Dengler T.J., Johnson D.R., Pober J.S. Human vascular endothelial cells stimulate a lower frequency of alloreactive CD8+ pre-CTL and induce less clonal expansion than matching B lymphoblastoid cells: development of a novel limiting dilution analysis method based on CFSE labeling of lymphocytes. J. Immunol. 166:2001;3846-3854.
5. Dennett N.S., Barcia R.N., McLeod J.D. Age associated decline in CD25 and CD28 expression correlate with an increased susceptibility to CD95 mediated apoptosis in T cells. Exp. Gerontol. 37:2002;271-283.
6. Dozmorov I.M., Lutsenko G.V., Sidorov L.A., Miller R.A. Analysis of cellular interactions in limiting dilution cultures. J. Immunol. Methods. 189:1996;183-196.
7. Effros R.B. Replicative senescence in the immune system: impact of the Hayflick limit on T-cell function in the elderly. Am. J. Hum. Genet. 62:1998;1003-1007.
8. Effros R.B., Globerson A. Hematopoietic cells and replicative senescence. Exp. Gerontol. 37:2002;191-196.
9. Ermann J., Szanya V., Ford G.S., Paragas V., Fathman C.G., Lejon K. CD4(+)CD25(+) T cells facilitate the induction of T cell anergy. J. Immunol. 167:2001;4271-4275.
10. Franceschi C. Cell proliferation, cell death and aging. Aging (Milano). 1:1989;3-15.
11. Frasca L., Scotta C., Lombardi G., Piccolella E. Human anergic CD4+ T cells can act as suppressor cells by affecting autologous dendritic cell conditioning and survival. J. Immunol. 168:2002;1060-1068.
12. Fukami-Kobayashi J., Mitsui Y. Cyclin D1 inhibits cell proliferation through binding to PCNA and cdk2. Exp. Cell Res. 246:1999;338-347.
13. Fukami-Kobayashi J., Mitsui Y. Overexpression of proliferating cell nuclear antigen in mammalian cells negates growth arrest by serum starvation and cell contact. Jpn. J. Cancer Res. 90:1999;286-293.
14. Fulcher D., Wong S. Carboxyfluorescein succinimidyl ester-based proliferative assays for assessment of T cell function in the diagnostic laboratory. Immunol. Cell. Biol. 77:1999;559-564.
15. Grubeck-Loebenstein B. Changes in the aging immune system. Biologicals. 25:1997;205-208.
16. Hasbold J., Gett A.V., Rush J.S., Deenick E., Avery D., Jun J., Hodgkin P.D. Quantitative analysis of lymphocyte differentiation and proliferation in vitro using carboxyfluorescein diacetate succinimidyl ester. Immunol. Cell. Biol. 77:1999;516-522.
17. Leng Q., Bentwich Z., Borkow G. CTLA-4 upregulation during aging. Mech. Ageing Dev. 123:2002;1419-1421.
18. Ligthart G.J., Corberand J.X., Fournier C., Galanaud P., Hijmans W., Kennes B., Muller-Hermelink H.K., Steinmann G.G. Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech. Ageing Dev. 28:1984;47-55.
19. Lyons A.B. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J. Immunol. Methods. 243:2000;147-154.
20. Lyons A.B., Hasbold J., Hodgkin P.D. Flow cytometric analysis of cell division history using dilution of carboxyfluorescein diacetate succinimidyl ester, a stably integrated fluorescent probe. Methods Cell Biol. 63:2001;375-398.
21. Manzotti C.N., Tipping H., Perry L.C., Mead K.I., Blair P.J., Zheng Y., Sansom D.M. Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells. Eur. J. Immunol. 32:2002;2888-2896.
22. McLeod J.D. Apoptotic capability in ageing T cells. Mech. Ageing Dev. 20:(121):2000;151-159.
23. Pawelec G., Sansom D., Rehbein A., Adibzadeh M., Beckman I. Decreased proliferative capacity and increased susceptibility to activation-induced cell death in late-passage human CD4+ TCR2+ cultured T cell clones. Exp. Gerontol. 31:1996;655-668.
24. Pawelec G., Muller R., Rehbein A., Hahnel K., Ziegler B.L. Finite lifespans of T cell clones derived from CD34+ human haematopoietic stem cells in vitro. Exp. Gerontol. 34:1999;69-77.
25. Pawelec G., Barnett Y., Forsey R., Frasca D., Globerson A., McLeod J., Caruso C., Franceschi C., Fulop T., Gupta S., Mariani E., Mocchegiani E., Solana R. T cells and aging, January 2002 update. Front Biosci. 7:2002;d1056-d1183.
26. Phelouzat M.A., Laforge T., Arbogast A., Quadri R.A., Boutet S., Proust J.J. Susceptibility to apoptosis of T lymphocytes from elderly humans is associated with increased in vivo expression of functional Fas receptors. Mech. Ageing Dev. 96:1997;35-46.
27. Pido-Lopez J., Imami N., Aspinall R. Both age and gender affect thymic output: more recent thymic migrants in females than males as they age. Clin. Exp. Immunol. 125:2001;409-413.
28. Rea I.M., McNerlan S.E., Alexander H.D. CD69, CD25, and HLA-DR activation antigen expression on CD3+ lymphocytes and relationship to serum TNF-alpha, IFN-gamma, and sIL-2R levels in aging. Exp. Gerontol. 34:1999;79-93.
29. Toussaint O., Remacle J., Dierick J.F., Pascal T., Frippiat C., Royer V., Chainiaux F. Approach of evolutionary theories of ageing, stress, senescence-like phenotypes, calorie restriction and hormesis from the view point of far-from-equilibrium thermodynamics. Mech. Ageing Dev. 123:2002;937-946.
30. Valenzuela H.F., Effros R.B. Divergent telomerase and CD28 expression patterns in human CD4 and CD8 T cells following repeated encounters with the same antigenic stimulus. Clin. Immunol. 105:2002;117-125.
31. Vallejo A.N., Nestel A.R., Schirmer M., Weyand C.M., Goronzy J.J. Aging-related deficiency of CD28 expression in CD4+ T cells is associated with the loss of gene-specific nuclear factor binding activity. J. Biol. Chem. 273:1998;8119-8129.
32. Wells A.D., Gudmundsdottir H., Turka L.A. Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J. Clin. Invest. 100:1997;3173-3183.
33. Wells A.D., Walsh M.C., Bluestone J.A., Turka L.A. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy. J. Clin. Invest. 108:2001;895-903.
34. Wick G., Grubeck-Loebenstein B. Immunity and aging. Dev. Comp. Immunol. 21:1997;455-460.
35. Witkowski J.M., Zmuda-Trzebiatowska E., Swiercz J.M., Cichorek M., Ciepluch H., Lewandowski K., Bryl E., Hellmann A. Modulation of the activity of calcium-activated neutral proteases (calpains) in chronic lymphocytic leukemia (B-CLL) cells. Blood. 100:2002;1802-1809.
36. Witkowski, J.M., Bryl, E., 2004. Paradoxical age-related cell cycle quickening of human CD4+ lymphocytes: a role for cyclin D1 and calpain. Exp. Gerontol. this issue.